Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
for
Liver Fibroses, Cirrhosis
Location: Dallas TX, Boston MA
Sponsor: Raymond Chung
Sex: All
Age: 18+
Code: NCT05028829
Phase 2, Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma
Location: Dallas TX, Chicago IL, Portland OR
Sponsor: University of Chicago
Sex: Male
Age: 18+
Code: NCT05726292
Phase 2, Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
for
Relapsed or Refractory Acute Myeloid Leukemia (AML),
Location: Dallas TX, Houston TX, Charleston SC
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT02074839
Phase 1, Recruiting
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
for
Coronary Disease
Location: Dallas TX
Sponsor: Methodist Health System
Sex: All
Age: 0+
Code: NCT06223633
Recruiting
Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
for
Langerhans Cell Histiocytosis
Location: Fort Worth TX
Sponsor: Cook Children's Health Care System
Sex: All
Age: 1 - 30
Code: NCT06582745
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multicenter Breast Cancer Biospecimen Registry
for
Breast Cancer
Location: Dallas TX, Redding CA
Sponsor: Luminist, Inc.
Sex: Female
Age: 40+
Code: NCT02712645
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Location: Fort Worth TX, Houston TX, San Antonio TX, Mobile AL,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
for
Crohn's Disease
Location: Fort Worth TX, Atlanta GA, Indianapolis IN, Dayton OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 2 - 17
Code: NCT05509777
Phase 3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Dallas TX, The Woodlands TX, Houston TX, Alexandria LA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Plano TX, Dallas TX, Bartlesville OK, Austin TX,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Waxahachie TX, Austin TX, Houston TX, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohn Disease
Location: Dallas TX, Tyler TX, Cedar Park TX, Bellaire TX,
Sponsor: Abivax S.A.
Sex: All
Age: 18 - 70+
Code: NCT06456593
Phase 2, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT06768905
Phase 1, Phase 2, Recruiting
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
for
Ovarian Cancer Recurrent
Location: Fort Worth TX, Shreveport LA, Oklahoma City OK,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06843447
Phase 1, Phase 2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Irving TX, Fort Worth TX, Palestine TX, Shreveport LA,